Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects

NCT04528641 is registered in ClinicalTrials.gov with ReiThera Srl as lead sponsor.

NCT NCT04528641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects
Lead sponsor
ReiThera Srl
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2020
Completion date
May 19, 2021
Enrollment
98 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19